Folinic acid-responsive seizures

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79097G40.3
Who is this for?
Show terms as
4Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Folinic acid-responsive seizures (also sometimes called folinic acid-responsive epilepsy) is a rare brain disorder that causes seizures in newborns and young infants that can be treated with a vitamin-like supplement called folinic acid. The condition is closely related to — and in many cases the same as — pyridoxine-dependent epilepsy (PDE), a disorder caused by changes in a gene called ALDH7A1. In both conditions, the brain does not process certain natural chemicals properly, which leads to repeated, hard-to-control seizures starting very early in life, often within the first days or weeks after birth. The seizures in this condition are unusual because they do not respond well to standard anti-seizure medications. However, when folinic acid (a form of the B-vitamin folate) is given, seizures often improve or stop completely. Some children also benefit from a low-lysine diet and vitamin B6 (pyridoxine or pyridoxal phosphate) supplementation. Without early treatment, the ongoing seizures can cause serious brain damage, developmental delays, and intellectual disability. Early diagnosis and prompt treatment are very important. Children who are identified and treated quickly — ideally within the first weeks of life — tend to have much better outcomes than those diagnosed later. Ongoing care from a team of specialists, including neurologists and metabolic doctors, is essential to manage this condition long-term.

Key symptoms:

Repeated seizures starting in the first days or weeks of lifeSeizures that do not respond to standard anti-seizure medicinesUnusual eye movements or staring spellsMuscle stiffness or jerking movementsIrritability and excessive crying in newbornsPoor feeding and difficulty swallowingLow muscle tone (floppy baby)Breathing problems during or after seizuresDevelopmental delays in reaching milestones like sitting or talkingIntellectual disability if treatment is delayed

Clinical phenotype terms (38)— hover any for plain English
Decreased CSF 5-methyltetrahydrofolate concentrationHP:0012446Cerebral hypomyelinationHP:0006808Multifocal epileptiform dischargesHP:0010841EEG with generalized slow activityHP:0010845Elevated CSF neopterin levelHP:0040204
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jan 2020

VALTOCO: FDA approved

Acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient®s usual seizure pattern in patients with epilepsy 6 years of age and older.

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Folinic acid-responsive seizures.

View clinical trials →

No actively recruiting trials found for Folinic acid-responsive seizures at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Folinic acid-responsive seizures community →

Specialists

4 foundView all specialists →
FT
Farah Thabet
Specialist
1 Folinic acid-responsive seizures publication
MA
Meshal Almutair
Specialist
1 Folinic acid-responsive seizures publication
KH
Khalid Hundallah
Specialist
1 Folinic acid-responsive seizures publication
BT
Brahim Tabarki
Specialist
1 Folinic acid-responsive seizures publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Folinic acid-responsive seizures.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Folinic acid-responsive seizuresForum →

No community posts yet. Be the first to share your experience with Folinic acid-responsive seizures.

Start the conversation →

Latest news about Folinic acid-responsive seizures

No recent news articles for Folinic acid-responsive seizures.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What dose of folinic acid does my child need, and how will we know if it is working?,Should my child also be taking vitamin B6, and if so, which form is best?,How strict does the low-lysine diet need to be, and can you refer us to a metabolic dietitian?,What is our emergency plan if my child has a prolonged seizure at home or school?,Should other family members be tested for the ALDH7A1 gene change?,What developmental therapies or early intervention services should we start right away?,How often will we need follow-up blood or urine tests to monitor treatment?

Common questions about Folinic acid-responsive seizures

What is Folinic acid-responsive seizures?

Folinic acid-responsive seizures (also sometimes called folinic acid-responsive epilepsy) is a rare brain disorder that causes seizures in newborns and young infants that can be treated with a vitamin-like supplement called folinic acid. The condition is closely related to — and in many cases the same as — pyridoxine-dependent epilepsy (PDE), a disorder caused by changes in a gene called ALDH7A1. In both conditions, the brain does not process certain natural chemicals properly, which leads to repeated, hard-to-control seizures starting very early in life, often within the first days or weeks a

How is Folinic acid-responsive seizures inherited?

Folinic acid-responsive seizures follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Folinic acid-responsive seizures typically begin?

Typical onset of Folinic acid-responsive seizures is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Folinic acid-responsive seizures?

4 specialists and care centers treating Folinic acid-responsive seizures are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.